[{"address1": "1990 Main Street", "address2": "Suite 750", "city": "Sarasota", "state": "FL", "zip": "34236", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7900", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and lantibiotics. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Sarasota, Florida.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Charles L. Pope CPA", "age": 72, "title": "Executive Chairman", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 112500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Huffman", "age": 52, "title": "CEO, President, CFO, Secretary & Treasurer", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 332500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Greg  Gironda", "title": "Head of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. James P. Kelly M.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.oragenics.com/?q=investors", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.26, "open": 1.24, "dayLow": 1.23, "dayHigh": 1.29, "regularMarketPreviousClose": 1.26, "regularMarketOpen": 1.24, "regularMarketDayLow": 1.23, "regularMarketDayHigh": 1.29, "payoutRatio": 0.0, "beta": 0.951, "forwardPE": -0.11574074, "volume": 107747, "regularMarketVolume": 107747, "averageVolume": 644658, "averageVolume10days": 202580, "averageDailyVolume10Day": 202580, "bid": 1.24, "ask": 1.26, "bidSize": 11, "askSize": 1, "marketCap": 1028658, "fiftyTwoWeekLow": 1.23, "fiftyTwoWeekHigh": 75.6, "fiftyDayAverage": 2.9732, "twoHundredDayAverage": 7.0883, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 28020, "profitMargins": 0.0, "floatShares": 629105, "sharesOutstanding": 822927, "sharesShort": 68033, "sharesShortPriorMonth": 289544, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.08270001, "heldPercentInsiders": 0.121079996, "heldPercentInstitutions": 0.012619999, "shortRatio": 0.06, "shortPercentOfFloat": 0.0845, "impliedSharesOutstanding": 822927, "bookValue": 0.192, "priceToBook": 6.5104165, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -10334078, "trailingEps": -30.6, "forwardEps": -10.8, "lastSplitFactor": "1:30", "lastSplitDate": 1748908800, "52WeekChange": -0.9537037, "SandP52WeekChange": 0.20277917, "quoteType": "EQUITY", "currentPrice": 1.25, "targetHighPrice": 2.0, "targetLowPrice": 2.0, "targetMeanPrice": 2.0, "targetMedianPrice": 2.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 3421078, "totalCashPerShare": 4.78, "totalDebt": 2554385, "quickRatio": 0.917, "currentRatio": 1.037, "debtToEquity": 1855.198, "returnOnAssets": -1.70959, "returnOnEquity": -7.48046, "grossProfits": -3792562, "freeCashflow": -5577585, "operatingCashflow": -7645223, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1754092673, "regularMarketTime": 1754078400, "exchange": "ASE", "messageBoardId": "finmb_774436", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.79365, "regularMarketPrice": 1.25, "cryptoTradeable": false, "postMarketChangePercent": 1.28, "postMarketPrice": 1.266, "postMarketChange": 0.016, "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.23 - 1.29", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 644658, "fiftyTwoWeekLowChange": 0.01999998, "fiftyTwoWeekLowChangePercent": 0.016260147, "fiftyTwoWeekRange": "1.23 - 75.6", "fiftyTwoWeekHighChange": -74.35, "fiftyTwoWeekHighChangePercent": -0.9834656, "fiftyTwoWeekChangePercent": -95.37037, "dividendDate": 1516579200, "earningsTimestamp": 1746820800, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -30.6, "epsForward": -10.8, "fiftyDayAverageChange": -1.7232001, "fiftyDayAverageChangePercent": -0.57957757, "twoHundredDayAverageChange": -5.8383, "twoHundredDayAverageChangePercent": -0.82365304, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.0 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1077719400000, "shortName": "Oragenics Inc.", "longName": "Oragenics, Inc.", "marketState": "CLOSED", "displayName": "Oragenics", "trailingPegRatio": null, "__fetch_time": "2025-08-02"}]